aod9604 slu pp 332 bloend AOD-9604 Dosage Guide: Complete Protocol for Safe Administration SLU-PP-332 Capsules: ERR Pan-Agonist for

Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body

For the 3.2 mg dose used here, add 2.5 mL to an 80 mg vial

These figures are provided for research reference only and do not constitute dosing recommendations

NNMT is overexpressed in adipose tissue of obese subjects, and its inhibition has been explored as a strategy to modulate methyl group flux and NAD+ precursor availability

However, large obesity trials did not show clinically meaningful weight loss, and regulators have raised concerns about immunogenicity and safety data gaps, which is why Better Med Spa restricts its use to clearly informed, highly selected clients